|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2009-8-20
|
|
pubmed:abstractText |
The purpose of this study was to investigate the mechanism by which the nonnucleoside reverse transcriptase inhibitor (NNRTI) nevirapine (NVP) increases high-density lipoprotein cholesterol (HDLc) in treatment-experienced human immunodeficiency virus-1 (HIV-1)-infected patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/APOA1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Dideoxynucleosides,
http://linkedlifedata.com/resource/pubmed/chemical/Nevirapine,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/abacavir
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1524-4636
|
|
pubmed:author |
pubmed-author:AckermansMariette TMT,
pubmed-author:Arenas-PintoAlejandroA,
pubmed-author:BrinkmanKeesK,
pubmed-author:FranssenRemcoR,
pubmed-author:HassinkEllyE,
pubmed-author:HuttenBarbaraB,
pubmed-author:KasteleinJohn JJJ,
pubmed-author:OesterholtRenéR,
pubmed-author:ReissPeterP,
pubmed-author:SankatsingRaaj RRR,
pubmed-author:SauerweinHans PHP,
pubmed-author:StorferStephen PSP,
pubmed-author:StroesErik SES
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1336-41
|
|
pubmed:meshHeading |
pubmed-meshheading:19667106-Adult,
pubmed-meshheading:19667106-Anti-HIV Agents,
pubmed-meshheading:19667106-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:19667106-Apolipoprotein A-I,
pubmed-meshheading:19667106-Cholesterol, HDL,
pubmed-meshheading:19667106-Dideoxynucleosides,
pubmed-meshheading:19667106-HIV Infections,
pubmed-meshheading:19667106-HIV-1,
pubmed-meshheading:19667106-Humans,
pubmed-meshheading:19667106-Kinetics,
pubmed-meshheading:19667106-London,
pubmed-meshheading:19667106-Magnetic Resonance Spectroscopy,
pubmed-meshheading:19667106-Male,
pubmed-meshheading:19667106-Middle Aged,
pubmed-meshheading:19667106-Netherlands,
pubmed-meshheading:19667106-Nevirapine,
pubmed-meshheading:19667106-RNA, Viral,
pubmed-meshheading:19667106-Reverse Transcriptase Inhibitors,
pubmed-meshheading:19667106-Treatment Outcome,
pubmed-meshheading:19667106-Up-Regulation,
pubmed-meshheading:19667106-Viral Load
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production.
|
|
pubmed:affiliation |
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
